LUNG TRANSPLANTATION
Clinical trials for LUNG TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANTATION trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could extend lung transplant survival
Disease control Not yet recruitingThis study tests a drug called fostamatinib in 30 adults who have received a lung transplant and developed donor-specific antibodies (DSA), which can lead to organ rejection. Participants take the drug or a placebo daily for 8 weeks while continuing standard care. The goal is to …
Matched conditions: LUNG TRANSPLANTATION
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New pain block may cut opioid use after lung transplant
Symptom relief Not yet recruitingThis study tests whether a long-acting painkiller (liposomal bupivacaine) given as a nerve block can reduce the need for opioids and improve pain control after lung transplant surgery. About 88 adults receiving a double lung transplant will be randomly assigned to get either the …
Matched conditions: LUNG TRANSPLANTATION
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC